Correlation Between Unicycive Therapeutics and Akebia Ther

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Akebia Ther, you can compare the effects of market volatilities on Unicycive Therapeutics and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Akebia Ther.

Diversification Opportunities for Unicycive Therapeutics and Akebia Ther

-0.26

Correlation Coefficient

Unicycive Therapeutics  Akebia Ther

Very good diversification

The 3 months correlation between Unicycive and Akebia is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Akebia Ther go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Akebia Ther

Given the investment horizon of 90 days Unicycive Therapeutics is expected to under-perform the Akebia Ther. But the stock apears to be less risky and, when comparing its historical volatility, Unicycive Therapeutics is 1.54 times less risky than Akebia Ther. The stock trades about -0.07 of its potential returns per unit of risk. The Akebia Ther is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  185.00  in Akebia Ther on December 29, 2024 and sell it today you would earn a total of  6.00  from holding Akebia Ther or generate 3.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Unicycive Therapeutics  vs.  Akebia Ther

Unicycive Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Unicycive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Akebia Ther

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Ther are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Akebia Ther sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Unicycive Therapeutics and Akebia Ther

The main advantage of trading using opposite Unicycive Therapeutics and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.

The idea behind Unicycive Therapeutics and Akebia Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.